Lassa virus

Lassa virus
Name	Lassa virus
Family	Arenaviridae
Genus	Arenavirus
Species	Lassa mammarenavirus
Genome	Bisegmented negative-sense RNA
Hosts	Humans, Mastomys natalensis
Transmission	Zoonotic, contact, nosocomial
Diseases	Lassa fever

Lassa virus is an arenavirus responsible for Lassa fever, a viral hemorrhagic illness first described in West Africa. Discovered in the late 1960s, the virus causes periodic outbreaks centered in Nigeria, Sierra Leone, Liberia and nearby regions, and has drawn attention from organizations such as World Health Organization, Centers for Disease Control and Prevention, and the Wellcome Trust. Research on Lassa virus involves collaborations among institutions including National Institutes of Health, London School of Hygiene & Tropical Medicine, Kenema Government Hospital, and Bernhard Nocht Institute.

Virology and Structure

Lassa virus belongs to the family Arenaviridae and the genus Arenavirus, sharing structural and genomic features with other members such as Lymphocytic choriomeningitis virus and Junín virus. The virion is enveloped and roughly spherical, containing host ribosomes that give virus particles their characteristic granular appearance noted by early electron microscopists like Albert Claude and George Palade. Its bisegmented negative-sense RNA genome comprises an S segment and an L segment that encode glycoproteins, nucleoprotein, matrix protein (Z), and RNA-dependent RNA polymerase, similar to organizational patterns seen in Arenavirus Tacaribe complex studies. The glycoprotein precursor is post-translationally cleaved by cellular proteases, a process studied in contexts such as furin research and protease inhibitors explored by teams at Roche and Gilead Sciences.

Transmission and Reservoirs

The principal reservoir is the multimammate rat, Mastomys natalensis, whose ecology has been documented in fieldwork by researchers affiliated with University of Ibadan, University of Sierra Leone, and CDC Nigeria. Human infections occur through exposure to rodent excreta, contact with contaminated food or household items, or inhalation of aerosolized particles in dwellings described in anthropological surveys by Paul Farmer-style public health teams. Secondary transmission includes nosocomial spread documented in outbreak investigations at Kenema Government Hospital and case series reported to Médecins Sans Frontières. Travel-associated importations have involved passengers routed through hubs like Heathrow Airport, John F. Kennedy International Airport, and Lagos Airport, prompting screening practices influenced by International Health Regulations.

Epidemiology and Clinical Features

Endemic zones span parts of West Africa with large urban centers such as Lagos, Freetown, Monrovia, and Abuja implicated in surveillance reports from Nigeria Centre for Disease Control and regional ministries of health. Annual incidence estimates vary, with tens of thousands of symptomatic cases and thousands of fatalities modeled in analyses by groups including Institute for Health Metrics and Evaluation and Harvard School of Public Health. Clinical presentation ranges from mild febrile illness to severe multisystem disease; classical features described in case series include fever, malaise, pharyngitis, retrosternal pain, and in severe cases bleeding, shock, and neurologic signs reminiscent of early descriptions from the 1969 era reported alongside investigators such as J. Casals and contemporaries. High-risk populations identified in cohort studies include pregnant women—especially during the third trimester—and healthcare workers documented in cluster reports from Kenema and Freetown.

Pathogenesis and Immune Response

Pathogenesis involves viral replication in macrophages, dendritic cells, and endothelial compartments, with immune modulation mediated by viral proteins including the nucleoprotein that antagonizes interferon pathways described in mechanistic studies at institutions such as Scripps Research Institute and Pasteur Institute. The dysregulated host response can lead to vascular leak and coagulopathy; immunopathology motifs echo findings from studies on other hemorrhagic arenaviruses like Argentine hemorrhagic fever. Adaptive immunity features neutralizing antibodies that often arise late in infection and T-cell responses correlated with viral clearance, subjects of vaccine research programs funded by agencies such as Bill & Melinda Gates Foundation and European Commission.

Diagnosis and Laboratory Methods

Laboratory confirmation relies on reverse transcription PCR, antigen detection assays, and serology (IgM/IgG), techniques standardized in reference laboratories such as National Institute for Communicable Diseases and USAMRIID. Viral culture requires Biosafety Level 4 containment used by specialized centers including Rocky Mountain Laboratories and Porton Down, limiting routine isolation. Point-of-care rapid diagnostic tests under evaluation have involved partnerships with companies like Cepheid and research consortia at London School of Hygiene & Tropical Medicine to expand field diagnostics in outbreak settings.

Treatment and Prevention

Ribavirin, an antiviral repurposed in multiple viral indications, remains the primary therapeutic with evidence from observational studies and historical trials supported by clinical units such as Kenema Government Hospital. Supportive care—fluid resuscitation, hemodynamic support, and management of complications—follows protocols aligned with clinical guidance from WHO and national ministries. Vaccine development efforts include platforms evaluated by IAVI, academic groups at Yale School of Medicine and University of Oxford, and candidate constructs ranging from live-attenuated to recombinant vectors; none had achieved widespread licensure as of recent consortium reports. Preventive measures emphasize rodent control, safe food storage practices promoted by UNICEF programs, and infection prevention and control in healthcare settings guided by CDC and WHO.

Public Health and Outbreak Response

Outbreak response integrates surveillance, case management, laboratory support, contact tracing, and community engagement coordinated through entities like African Union, WHO Regional Office for Africa, and national public health agencies including Nigeria Centre for Disease Control and Sierra Leone Ministry of Health. International aid responses have involved Médecins Sans Frontières, International Federation of Red Cross and Red Crescent Societies, and donor partners such as USAID during major episodes. Research priorities emphasized by global forums including World Health Assembly and funded by organizations like Wellcome Trust focus on diagnostics, therapeutics, vaccine development, and strengthened health systems resilience to reduce Lassa fever burden.

Category:Arenaviridae